Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Sponsor: Dong-A ST Co., Ltd.
Summary
This study is a multicenter, double-blind, active-controlled, randomized, parallel clinical trial to evaluate the efficacy and safety of DA-2811 when added to ongoing BT-1 and BT-2 combination therapy in patients with type 2 diabetes who have inadequate glycemic control
Official title: A Multicenter, Double-blind, Active-controlled, Randomized, Parallel Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
288
Start Date
2025-11
Completion Date
2027-06
Last Updated
2025-11-20
Healthy Volunteers
No
Conditions
Interventions
DA-2811
DA-2811 + DA-2811-R2, orally, once daily
DA-2811-C
DA-2811-C + DA-2811-R1, orally, once daily
Locations (1)
Samsung Medical Center
Seoul, South Korea